As heated as the stock market is now, investors may feel that there is not a good investment to be found. But even though there might not be any dollars selling for pennies, we can still find good-quality businesses selling at below their intrinsic value. With that said, here are two Singapore stocks that could be excellent additions to a value investor’s portfolio. King of the jungle Haw Par Corporation Limited (SGX: H02) manufactures healthcare products and owns long-term investments in stocks, property, and leisure assets. Its principal activity is the licensing of the Tiger brand, which includes products such as Tiger Balm and Kwan Loong. It also owns 74.8 million shares of United Overseas Bank Limited (SGX: U11) and 72.0 million UOL Group Limited (SGX: U14), along with four prope

Passive income is perhaps the ultimate goal of most investors in Singapore. The thought of growing your wealth without lifting a finger is extremely appealing to retirees who are looking to maintain their lifestyles after exiting the workforce. With that said, I decided to do a quick review of which investment can provide the biggest passive income cash flows. Property It is no secret that Singaporeans love investing in property — and perhaps for good reason, too. Property in Singapore has appreciated at an unprecedented rate due to the limited land supply and population growth. The strong economy and low interest rates have also enabled more people in Singapore to afford their own homes, driving home prices up in the process. To calculate the rental yield of a property, I will use

Listed back in 1969, Haw Par Corporation Limited (SGX: H02) is a consumer healthcare business that also invests in strategic assets. Here’s what potential investors should know about the company. Healthcare segment The principal operating activity of the group is the licensing and distribution of the Tiger brand, which includes Tiger Balm and Kwan Loong. While some might assume that Tiger brand is old-school, the sale of Tiger products has actually been growing consistently over the past few decades. Tiger Balm is now sold in 100 countries all over the world. In 2018, the upward sales trend for Tiger Balm in various markets in Southeast Asia, the Indo-China region, and Europe continues. Besides Tiger balm, the company has also extended its product range, with Tiger Balm Neck & Shou

If you are new to investing on the Singapore Exchange (SGX), you may not know that some of Singapore’s biggest and most popularly traded companies are actually home-grown conglomerates which are run by some of Singapore’s richest families. Besides playing an integral part in growing Singapore to become the successful city-state that it is today, these companies have also generated good returns for its owners and investors over the past years. In this week’s edition of 4 Stocks This Week, we take a closer look at some of these local family empires to find out how well they have been performing. Haw Par Corporation Limited (SGX: H02) Haw Par Corporation and its subsidiaries is in the business of manufacturing and selling pharmaceutical and healthcare products. Its most recognisable bra

Haw Par Corporation Ltd (SGX: H02) continues to see good growth in its healthcare division.

More interesting things about Haw Par Corporation Ltd (SGX: H02) that investors might have missed.

We're using Haw Par Corporation Ltd’s (SGX: H02) cost structure to determine its attractiveness as an investment.

From $3.00 in 2009 to $14 in 2018, Haw Par share price enjoyed one of the most incredible bull runs in Singapore Exchange as it surged more than four fold within the span of a decade. The berserk run of Haw Par share price certainly created much wealth for long-time investors but its bullish run seemed to hit the skid for the past one year. What has changed that caused the malaise form of Haw Par share price? Since my last coverage on this counter in 2017, Haw Par share price continued to amaze me with its adventure. Unknown to many investors, this counter is actually a proxy for UOB share price. This is because Haw Par Corp holds 73 million UOB shares under its Investments segment. If investors observed Haw Par share price carefully, it would mirror exactly that of UOB share price for the

Haw Par Corporation Ltd (SGX: H02), a diversified healthcare conglomerate, rewarded shareholders on its 50th anniversary.